Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

569 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.
Boogerd LSF, Hoogstins CES, Gaarenstroom KN, de Kroon CD, Beltman JJ, Bosse T, Stelloo E, Vuyk J, Low PS, Burggraaf J, Vahrmeijer AL. Boogerd LSF, et al. Among authors: low ps. Oncotarget. 2017 Dec 11;9(1):791-801. doi: 10.18632/oncotarget.23155. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416655 Free PMC article.
Assessment of folate receptor-β expression in human neoplastic tissues.
Shen J, Putt KS, Visscher DW, Murphy L, Cohen C, Singhal S, Sandusky G, Feng Y, Dimitrov DS, Low PS. Shen J, et al. Among authors: low ps. Oncotarget. 2015 Jun 10;6(16):14700-9. doi: 10.18632/oncotarget.3739. Oncotarget. 2015. PMID: 25909292 Free PMC article.
Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue.
Roy J, Putt KS, Coppola D, Leon ME, Khalil FK, Centeno BA, Clark N, Stark VE, Morse DL, Low PS. Roy J, et al. Among authors: low ps. Oncotarget. 2016 Mar 22;7(12):14605-15. doi: 10.18632/oncotarget.7522. Oncotarget. 2016. PMID: 26910279 Free PMC article.
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
Tummers QR, Hoogstins CE, Gaarenstroom KN, de Kroon CD, van Poelgeest MI, Vuyk J, Bosse T, Smit VT, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Tummers QR, et al. Among authors: low ps. Oncotarget. 2016 May 31;7(22):32144-55. doi: 10.18632/oncotarget.8282. Oncotarget. 2016. PMID: 27014973 Free PMC article. Clinical Trial.
A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.
Hoogstins CE, Tummers QR, Gaarenstroom KN, de Kroon CD, Trimbos JB, Bosse T, Smit VT, Vuyk J, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Hoogstins CE, et al. Among authors: low ps. Clin Cancer Res. 2016 Jun 15;22(12):2929-38. doi: 10.1158/1078-0432.CCR-15-2640. Clin Cancer Res. 2016. PMID: 27306792 Clinical Trial.
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma.
Szigetvari NM, Dhawan D, Ramos-Vara JA, Leamon CP, Klein PJ, Ruple AA, Heng HG, Pugh MR, Rao S, Vlahov IR, Deshuillers PL, Low PS, Fourez LM, Cournoyer AM, Knapp DW. Szigetvari NM, et al. Among authors: low ps. Oncotarget. 2018 Dec 11;9(97):37042-37053. doi: 10.18632/oncotarget.26455. eCollection 2018 Dec 11. Oncotarget. 2018. PMID: 30651934 Free PMC article.
569 results